Last reviewed · How we verify
BlueChew
At a glance
| Generic name | BlueChew |
|---|---|
| Also known as | Sildenafil chewable tablet |
| Sponsor | Aspargo Labs, Inc |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Hezkue®, Hezkue Turbo®, and Commercial Sildenafil Products in Fed Healthy Male Subject (PHASE1)
- Phase 2 Efficacy Study of Sildenafil Products in Adult Men With Erectile Dysfunction (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- BlueChew CI brief — competitive landscape report
- BlueChew updates RSS · CI watch RSS
- Aspargo Labs, Inc portfolio CI